1.The effects of chlorpromazine and nicotine on random-pattern skin flaps.
Jeong Cheol KIM ; Jung Soo HONG ; Dong Bo SUH ; Kyung Ho LEE ; Jung Hyun SEUL
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1992;19(3):390-399
No abstract available.
Chlorpromazine*
;
Nicotine*
;
Skin*
2.Blue-gray Pigmentation Induced by Chlorpromazine.
Sin Wook CHUN ; Sang Yoon LEE ; Hyun Ok SON ; Suk Young LEE ; Han Kyoung CHO ; Byung In RO ; Han Gyu CHOI
Korean Journal of Dermatology 2015;53(8):659-661
No abstract available.
Chlorpromazine*
;
Hyperpigmentation
;
Pigmentation*
3.Symptomatic treatment of painful, absolute glaucoma
Sangalang Ma. Marither ; Lauenberger Edgar-Felipe U
Philippine Journal of Ophthalmology 2001;26(3):63-65
To determine if retrobulbar administration of chlorpromazine can alleviate the pain and promote lowering of intraocular pressure in absolute glaucoma, ten patients with painful absolute glaucoma received retrobulbal injection of 1.5 cc each of xylocaine and chlorpromazine. Pre- and post- injection intraocular pressures and pain grading were compared and analyzed statistically using the T test (L=0.01, 99.9%).Signs and symptoms of hypotension were monitored.A 75% reduction of pain was noted one hour post-injection and 95% three months post-injection in 9/10 patients.Intraocular pressure decreased by 30% in 7/10 patients one day post injection.Pressure-lowering effect however was not sustained for three months
Human
;
GLAUCOMA
;
CHLORPROMAZINE
;
XYLOCAINE
4.Prolonged Low-dose Chlorpromazine Therapy Induced Skin Pigmentation and Corneal and Lens Opacities.
Bokwon PARK ; Jun Yeong PARK ; YEJI JANG ; Eun Byul CHO ; Eun Joo PARK ; Kwang Ho KIM ; Kwang Joong KIM
Korean Journal of Dermatology 2018;56(9):575-577
No abstract available.
Cataract*
;
Chlorpromazine*
;
Skin Pigmentation*
;
Skin*
5.A case of chlorpromazine induced priapism.
Moon Ho KANG ; Bong Cheol SEOK ; Sung Hak YANG
Korean Journal of Urology 1993;34(4):737-739
Priapism is a well recognized complication of some oral medications. Those most commonly cited are: antipsychotic drugs, especially the phenolhiazine: trazodone and chlorpromazine :and the antihyperlensive drugs hydralazine, guanethidine and prazocin. We report a case or priapism associated with the use of chlorpromazine who experienced 2 episodes or priapism and never experience priapism after cessation of the drug.
Antipsychotic Agents
;
Chlorpromazine*
;
Guanethidine
;
Hydralazine
;
Priapism*
;
Trazodone
6.The Effects of the Tranquilizers on Heterophoria.
Young Soo HAHN ; Dong Ho YOUN ; Won Sik YOUN
Journal of the Korean Ophthalmological Society 1968;9(4):13-20
In 54 cases with heterophoria, the effects of the tranquilizers were studied. The minimum doses of two kinds of tranquilizers i.e., phenothiazine derivative (chlorpromazine) and benzodiazepine derivative (oxazepam) were given for 3 days. The results were as follows: 1. In 18 cases (43%) of the 30 cases who complained asthenopia, the symptom was relieved to some extent. The improvement of the symptom occurred with decrease in the Jateral phoria in 13 cases, and with increase in fusional amplitude in 13 cases. 2, There were no changes in the lateral phoria in 31 cases (59%) at distance, but at near, in 27 cases (52%) there was decrease in the lateral phoria. The amount of the increment or decrement in prism diopters was somewhat larger at near than at distance, and also somewhat larger in cases, in which the initial lateral phoria before medication is high, than in the cases with low initial lateral phoria. 3, There were no changes in the fusional amplitude in 24 cases (46%) at distance, but at near, in 28 cases (55 %) there was the increase in fusional amplitude. The changes in the amount of the increment or decrement in the fusional al1}plitude were similar to that of the changes in the amount in lateral phoria. 4, There were no remarkable changes in vertical phorias. 5. In exophoria there were no remarkable differences between subjects given chlorpromazine and those gIven oxazepam.
Asthenopia
;
Benzodiazepines
;
Chlorpromazine
;
Exotropia
;
Oxazepam
;
Strabismus
7.Electroencephalographic effects of chlorpromazine in rats.
The Korean Journal of Physiology and Pharmacology 1999;3(3):245-250
The effects of an antipsychotic, chlorpromazine, on the electroencephalogram (EEG) were observed while rats were awake but immobile. The time course and the dose-dependency of the EEG changes were examined. The method of the power spectrum analysis was used to examine the EEG changes by the drug. The bands were divided into delta (1 ~ 3.5 Hz), theta (3.5 ~ 8 Hz), alpha (8 ~ 13 Hz), beta1 (13 ~ 21 Hz), beta2 (21 ~ 30 Hz) and gamma (30 ~ 50 Hz). In rats, the low dose of chlropromazine (1 mg/kg, i.p.) produced a significant increase in the power of the beta1 band. The higher doses (5, 10 mg/kg, i.p.) produced a significant increase in the power of the delta, theta, alpha and beta1 bands, and the decrease in the power of the gamma band. The powers of the bands changed dose-dependently. Then, the authors discussed whether the EEG effects produced by a drug are associated with the accompanying behavioral changes specifically.
Animals
;
Chlorpromazine*
;
Electroencephalography
;
Rats*
;
Spectrum Analysis
8.Erectile Response of Intracavernous Injection of New Triple Agents, Chlorpromazine, Papaverine, and Alprostadil.
Korean Journal of Urology 2003;44(11):1121-1123
PURPOSE: This study was aimed to compare the erectile response when phentolamine of intracavernous trimix(papaverine, phentolamine, alprostadil) was replaced with chlorpromazine. MATERIALS AND METHODS: A total of 65 patients with erectile dysfunction(63.3+/-9.19 years of age) who had already used intracavernous injection with trimix(4.5+/-2.12 years) were recruited for this study. The erection quality and adverse reactions of chlorpromazine solution were compared with those of trimix. RESULTS: Among 65 patients, the erection quality of the intracavernous chlorpromazine solution compared to that of trimix was worse in 26 patients(40%), better in 8(12.3%) and similar in 31(47.7%) when injected at the clinic. Among 45 patients who used the chlorpromazine solution for intracavernous self-injection at home for more than 3 months, however, the erection quality was worse in 13(28.9%), better in 8(17.8%) and similar in 24(53.3%). Intracavernous chlorpromazine solution-either injected at the clinic or self-injected-showed no significant adverse reaction. CONCLUSIONS: Chlorpromazine could be a safe and effective substitude of phentolamine of trimix.
Alprostadil*
;
Chlorpromazine*
;
Erectile Dysfunction
;
Humans
;
Male
;
Papaverine*
;
Phentolamine
9.Genetic Safety Study of Chlorpromazine.
Han Gyu KIM ; Yun Hee SHON ; Kwang Heun LEE ; Tae Ho YOON ; Kyung Soo NAM
Journal of Korean Neuropsychiatric Association 2000;39(3):629-637
OBJECT: The aim of this study is to determine whether exposure to chlorpromazine causes mutagenicity and genetic disorders. METHOD: Ames (Salmonella typhimurium) test and Rec assay (Bacillus subtilis) were used as indicators for DNA damage. Furthermore, the levels of umu operon expression by measuring the beta-galactosidase activity were monitered with the SOS umu test using S. typhimurium 1535 containing plasmid pSK1002. And the host-mediated assay was used to investigate the muta-genicity of chlorpromazine after the activation with in vivo metabolic systems. RESULTS: From the results, chlorpromazine did not affect DNA of S. typhimurium and B. subtilis strains and showed no mutagenicity at the all concentrations tested. These phenomena was also similar to that after metabolic activation of chlorpromazine in in vivo system. CONCLUSION: These results suggested that chlorpromazine did not show the mutagenicity and genotoxicity by four different methods used in this study.
beta-Galactosidase
;
Biotransformation
;
Chlorpromazine*
;
DNA
;
DNA Damage
;
Operon
;
Plasmids
10.A Case of Tardive Blepharospasm.
Seong Ryong WOO ; Seok Young JEONG ; Eui Seong LIM ; Seul Ki JEONG ; Man Wook SEO
Journal of the Korean Neurological Association 2005;23(4):565-567
Blepharospasm is a focal dystonia that consists of repetitive involuntary spasmodic contractions of the orbicularis oculi muscle. A 27-year-old man was admitted with ptosis and involuntary blinking in both eyes. He was diagnosed as having schizophrenia when he was 15 years old and medicated with chlorpromazine for 12 years. After excluding all the possible etiopathological causes of the blepharospam, the offending drug was discontinued and changed to an atypical antipsychotic, clozapine. Clozapine was increased up to 75 mg in the 7th day of admission, and the symptoms were slowly ameliorated.
Adolescent
;
Adult
;
Blepharospasm*
;
Blinking
;
Chlorpromazine
;
Clozapine
;
Dystonic Disorders
;
Humans
;
Schizophrenia